上海金畔生物科技有限公司可以定制不同序列多肽，可以访问官网了解更多产品信息。
| 名称 | DPhe-DPhe-DNle-DArg-NH4-Picolyl |
| 编码 | |
| 别名 | DPhe-DPhe-DNle-DArg-NH4-Picolyl |
| 纯度 | 80%，90%，95%，98%，99% |
| 重量 | 1mg,5mg,10mg,50mg,100mg,1g |
| 序列（单字母缩写） | ff-DNle-r-NH4Picolyl |
| 序列（三字母缩写） | H-DPhe-DPhe-DNle-DArg-NH-4-Picolyl (trifluoroacetate salt) |
| 基本描述 | |
| 溶解度 | |
| 分子量 | 671.83 |
| 化学式 | C36H49N9O4 |
| 存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| 注释 | |
| Documents |  |
| Figures |  |
| Reference | |
| C端 | |
| N端 | |
| 化学桥 |
上海金畔生物科技有限公司可以定制不同序列多肽，可以访问官网了解更多产品信息。
| 名称 | [DArg1,DPhe5,DTrp7,9,Leu11] Substance P |
| 编码 | [96736-12-8] |
| 别名 | [DArg1,DPhe5,DTrp7,9,Leu11] Substance P |
| 纯度 | 80%，90%，95%，98%，99% |
| 重量 | 1mg,5mg,10mg,50mg,100mg,1g |
| 序列（单字母缩写） | rPKPfQwFwLL-NH2 |
| 序列（三字母缩写） | H-DArg-Pro-Lys-Pro-DPhe-Gln-DTrp-Phe-DTrp-Leu-Leu-NH2?(trifluoroacetate salt) |
| 基本描述 | This neuropeptide was found in the gut as well as in the brain. It is responsible for a number of excitatory effects on both central and peripheral neurons. It contracts smooth muscle, constricts bronchioles and increases capillary permeability. When released from afferent nerves, it causes a neurogenic inflammatory response, including mast cell degranulation. |
| 溶解度 | |
| 分子量 | 1516.86 |
| 化学式 | C79H109N19O12 |
| 存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| 注释 | |
| Documents | ![[DArg1,DPhe5,DTrp7,9,Leu11] Substance P 编码 [96736-12-8]](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_634896ece38cd.png) |
| Figures | ![[DArg1,DPhe5,DTrp7,9,Leu11] Substance P 编码 [96736-12-8]](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_634896ed42efe.jpg) |
| Reference | B.Holst et al., Mol. Endocrinol., 17, 2201 (2003) D.A.Jones et al., Peptides, 16, 777 (1995) J.G.Reeve and N.M.Bleehen, Biochem. Biophys. Res. Commun., 199, 1313 (1994) H.Houben and C.Denef, Peptides, 14, 109 (1993) P.J.Woll and E.Rozengurt, Proc. Natl. Acad. Sci. USA, 85, 1859 (1988) K.Tsou et al., Eur. J. Pharmacol., 110, 155 (1985) |
| C端 | |
| N端 | |
| 化学桥 |
上海金畔生物科技有限公司可以定制不同序列多肽，可以访问官网了解更多产品信息。
| 名称 | [DArg2,Lys4]-Dermorphin (1-4), amide |
| 编码 | |
| 别名 | [DArg2,Lys4]-Dermorphin (1-4), amide |
| 纯度 | 80%，90%，95%，98%，99% |
| 重量 | 1mg,5mg,10mg,50mg,100mg,1g |
| 序列（单字母缩写） | Y-DArg-FK-NH2 |
| 序列（三字母缩写） | H-Tyr-DArg-Phe-Lys-NH2?(trifluoroacetate salt) |
| 基本描述 | μ-opioid receptor and selective tetrapeptide analog of dermorphin that exhibits more potent and longer-lasting analgesic activities than morphine. |
| 溶解度 | |
| 分子量 | 611.8 |
| 化学式 | C30H45N9O5 |
| 存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| 注释 | |
| Documents | ![[DArg2,Lys4]-Dermorphin (1-4), amide 编码](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_634896bf55f34.png) |
| Figures | ![[DArg2,Lys4]-Dermorphin (1-4), amide 编码](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_634896bfa7f97.jpg) |
| Reference | |
| C端 | |
| N端 | |
| 化学桥 |
上海金畔生物科技有限公司可以定制不同序列多肽，可以访问官网了解更多产品信息。
| 名称 | [DArg2,Sar4] Dermorphin (1-4) |
| 编码 | |
| 别名 | [DArg2,Sar4] Dermorphin (1-4) |
| 纯度 | 80%，90%，95%，98%，99% |
| 重量 | 1mg,5mg,10mg,50mg,100mg,1g |
| 序列（单字母缩写） | Y-DArg-F-Sar |
| 序列（三字母缩写） | H-Tyr-DArg-Phe-Sar-OH (trifluoroacetate salt) |
| 基本描述 | Peptide that produces significant antinociception in morphine-tolerant mice. It is also the most potent of the (DArg2)-dermorphin fragments and more stable to enzymatic cleavage. |
| 溶解度 | |
| 分子量 | 555.6 |
| 化学式 | C27H37N7O6 |
| 存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| 注释 | |
| Documents | ![[DArg2,Sar4] Dermorphin (1-4) 编码](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_634896b693b1b.png) |
| Figures | ![[DArg2,Sar4] Dermorphin (1-4) 编码](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_634896b6e7e7d.jpg) |
| Reference | Y. Sasaki et al., BBRC, 120, 214 (1984) |
| C端 | |
| N端 | |
| 化学桥 |
上海金畔生物科技有限公司可以定制不同序列多肽，可以访问官网了解更多产品信息。
| 名称 | [DArg2] Dermorphin (1-4), amide |
| 编码 | |
| 别名 | [DArg2] Dermorphin (1-4), amide |
| 纯度 | 80%，90%，95%，98%，99% |
| 重量 | 1mg,5mg,10mg,50mg,100mg,1g |
| 序列（单字母缩写） | Y-DArg-FG-NH2 |
| 序列（三字母缩写） | H-Tyr-DArg-Phe-Gly-NH2?(trifluoroacetate salt) |
| 基本描述 | Putative endogenous agonist of the opioid receptor-like1 (ORL1) receptor that acts as a transmitter in the brain by modulating nociceptive and locomotor behavior. |
| 溶解度 | |
| 分子量 | 540.6 |
| 化学式 | C26H36N8O5 |
| 存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| 注释 | |
| Documents | ![[DArg2] Dermorphin (1-4), amide 编码](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_634896a776192.png) |
| Figures | ![[DArg2] Dermorphin (1-4), amide 编码](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_634896a7c6c1d.jpg) |
| Reference | K. Suzuki et al., Peptide Chemistry, 1985, 203 (1986) |
| C端 | |
| N端 | |
| 化学桥 |
上海金畔生物科技有限公司可以定制不同序列多肽，可以访问官网了解更多产品信息。
| 名称 | [N-Admantaneacetyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin |
| 编码 | [130942-96-0] |
| 别名 | [N-Admantaneacetyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin |
| 纯度 | 80%，90%，95%，98%，99% |
| 重量 | 1mg,5mg,10mg,50mg,100mg,1g |
| 序列（单字母缩写） | N-Adamantaneacetyl-DArg-RP-Hyp-G-Thi-S-DPhe-Thi-R |
| 序列（三字母缩写） | N-Adamantaneacetyl-DArg-Arg-Pro-Hyp-Gly-Thi-Ser-DPhe-Thi-Arg-OH (trifluoroacetate salt) |
| 基本描述 | Highly potent bradykinin antagonist. |
| 溶解度 | |
| 分子量 | 1469.8 |
| 化学式 | C68H98N19O14S2 |
| 存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| 注释 | |
| Documents | ![[N-Admantaneacetyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin 编码 [130942-96-0]](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_6348900e5030a.png) |
| Figures | ![[N-Admantaneacetyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin 编码 [130942-96-0]](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_6348900ea9d13.jpg) |
| Reference | B. Lammek et al., Peptides, 11, 1041 (1990) |
| C端 | |
| N端 | |
| 化学桥 |
上海金畔生物科技有限公司可以定制不同序列多肽，可以访问官网了解更多产品信息。
| 名称 | [N-Admantanecarbonyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin |
| 编码 | |
| 别名 | [N-Admantanecarbonyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin |
| 纯度 | 80%，90%，95%，98%，99% |
| 重量 | 1mg,5mg,10mg,50mg,100mg,1g |
| 序列（单字母缩写） | N-Adamantanecarbonyl-DArg-RP-Hyp-G-Thi-S-DPhe-Thi-R |
| 序列（三字母缩写） | N-Adamantanecarbonyl-DArg-Arg-Pro-Hyp-Gly-Thi-Ser-DPhe-Thi-Arg-OH (trifluoroacetate salt) |
| 基本描述 | |
| 溶解度 | |
| 分子量 | 1455.8 |
| 化学式 | C67H96N19O14S2 |
| 存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| 注释 | |
| Documents | ![[N-Admantanecarbonyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin 编码](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_63489006a0fd8.png) |
| Figures | ![[N-Admantanecarbonyl-DArg0-Hyp3,Thi5,8,DPhe7] Bradykinin 编码](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_6348900702a27.jpg) |
| Reference | |
| C端 | |
| N端 | |
| 化学桥 |
上海金畔生物科技有限公司可以定制不同序列多肽，可以访问官网了解更多产品信息。
| 名称 | Ac-[DArg2] GHRF(1-29), amide, human |
| 编码 | |
| 别名 | Ac-[DArg2] GHRF(1-29), amide, human |
| 纯度 | 80%，90%，95%，98%，99% |
| 重量 | 1mg,5mg,10mg,50mg,100mg,1g |
| 序列（单字母缩写） | Ac-Y-DArg-DAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |
| 序列（三字母缩写） | Ac-Tyr-DArg-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2(trifluoroacetate salt) |
| 基本描述 | |
| 溶解度 | |
| 分子量 | 3485.1 |
| 化学式 | C154H255N47O43S1 |
| 存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| 注释 | |
| Documents | ![Ac-[DArg2] GHRF(1-29), amide, human 编码](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_63488977ce0a5.png) |
| Figures | ![Ac-[DArg2] GHRF(1-29), amide, human 编码](http://www.fluoroprobe.com/wp-content/uploads/2022/10/20221013_634889782b2be.jpg) |
| Reference | P. Robberecht et al., The Endocrine Society, 117, 1759 (1985) |
| C端 | |
| N端 | |
| 化学桥 |